Escalon Medical (ESMC) Stock Price, News & Analysis

Company Overview

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. Escalon Medical Corp. was incorporated in 1987 and is headquartered in Wayne, Pennsylvania.

Key Stats

• Today's Range: $0.19 to $0.19
• 50-Day Range: $0.12 to $0.19
• 52-Week Range: $0.11 to $0.27
• Volume: N/A
• Average Volume: 3,358 shs
• Market Capitalization: $1.40 million
• P/E Ratio: 18.87
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Escalon Medical Stock Analysis - MarketRank™

Escalon Medical scored higher than 17% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Escalon Medical.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Escalon Medical is 18.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.55.

Price to Earnings Ratio vs. Sector

The P/E ratio of Escalon Medical is 18.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.49.

Price to Book Value per Share Ratio

Escalon Medical has a P/B Ratio of 0.99. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the outstanding shares of Escalon Medical have been sold short.

Short Interest Ratio / Days to Cover

Escalon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Escalon Medical does not currently pay a dividend.

Dividend Growth

Escalon Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.00% of the outstanding shares of Escalon Medical have been sold short.

Short Interest Ratio / Days to Cover

Escalon Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

News Sentiment

Escalon Medical has a news sentiment score of -0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

Search Interest

1 people have searched for ESMC on MarketBeat in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Escalon Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.90% of the stock of Escalon Medical is held by insiders.

ESMC Stock Analysis - Frequently Asked Questions

How have ESMC shares performed this year?

Escalon Medical's stock was trading at $0.1255 on January 1st, 2025. Since then, ESMC shares have increased by 50.2% and is now trading at $0.1885.
View the best growth stocks for 2025 here.

How were Escalon Medical's earnings last quarter?

Escalon Medical Corp. (OTCMKTS:ESMC) issued its earnings results on Friday, February, 14th. The medical equipment provider reported $0.02 EPS for the quarter. The medical equipment provider earned $3.22 million during the quarter. Escalon Medical had a net margin of 1.43% and a trailing twelve-month return on equity of 14.79%.

How do I buy shares of Escalon Medical?

Shares of ESMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Escalon Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Escalon Medical investors own include XTI Aerospace (XTIA), Co-Diagnostics (CODX), Digital Ally (DGLY), Kopin (KOPN), Onconova Therapeutics (ONTX), Precipio (PRPO) and Tonix Pharmaceuticals (TNXP).

Company Calendar

• Last Earnings: 2/14/2025
• Today: 2/22/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:ESMC
• Previous Symbol: NASDAQ:ESMC
• CUSIP: N/A
• CIK: 862668
• Web: www.escalonmedical.com
• Phone: (610) 688-6830
• Fax: 610-688-3641
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.01
• Trailing P/E Ratio: 18.85
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-130,000.00
• Net Margins: 1.43%
• Pretax Margin: 1.53%
• Return on Equity: 14.79%
• Return on Assets: 3.75%

Debt

• Debt-to-Equity Ratio: 0.18
• Current Ratio: 1.95
• Quick Ratio: 0.99

Sales & Book Value

• Annual Sales: $11.98 million
• Price / Sales: 0.12
• Cash Flow: $0.04 per share
• Price / Cash Flow: 5.23
• Book Value: $0.19 per share
• Price / Book: 0.99

Miscellaneous

• Outstanding Shares: 7,420,000
• Free Float: 7,274,000
• Market Cap: $1.40 million
• Optionable: Not Optionable
• Beta: -0.27